Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease
- Authors:
- Lijun Sun
- Yuewen Hao
- Xiaowei Nie
- Xuexin Zhang
- Guangxiao Yang
- Quanying Wang
View Affiliations
Affiliations: Department of Radiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Xi'an Huaguang Bioengineering Limited Company, Xi'an, Shaanxi 710025, P.R. China
- Published online on: August 20, 2012 https://doi.org/10.3892/etm.2012.674
-
Pages:
811-814
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The objective of this study was to investigate the effect of the PR39 recombinant adeno-associated virus (AAV) controlled by the hypoxia-responsive element (HRE) on gene therapy of ischemic heart disease. The minimal HRE was artificially synthesized and the AAV vector controlled by HRE was introduced with NT4-TAT-His-PR39 to investigate the expression of AAV-PR39 in hypoxic vascular endothelial cells (VEC) of human umbilical vein (CRL-1730 cell line) and the angiogenesis-promoting effect in pigs with acute myocardial infraction (AMI). The minimal HRE/CMV was designed and artificially synthesized using the PCR method and cloned with the T vector cloning method. The pSS-HRE-CMV-NT4-6His-PR39-PolyA-AAV plasmid was constructed. Using the calcium phosphate precipitation method, HEK-293 cells were co-transfected with three plasmids to produce the recombinant virus. An equal volume of pSS-HRE-CMV-NT4-6His-PR39-PolyA-AAV and enterovirus (EV, blank virus) was transfected into CRL-1730 cell lines, respectively. The immunohistochemical method was used to assay the expression of 6xHis in CRL-1730 cell lines and the expression of PR39 under hypoxia. Eighteen AMI miniature pigs were randomized into the experimental group (HRE-AAV-PR39 group), control group 1 (physical saline group) and control group 2 (EV group). The area of ischemia was assessed with conventional MRI and myocardium perfusion MRI. Pigs were sacrificed at preset time-points to obtain samples of ischemic myocardium. Morphological and pathological data were collected. According to data in the literature and databases, the minimal HRE was designed and synthesized with the PCR method. A large number of HREs were connected to modified pSSHGAAV (pSSV9int-/XbaI) vector followed by insertion of the NT4-6His-PR39 gene segment and, thus, the recombinant plasmid pSS-HRE-CMV-NT4-6His-PR39-PolyA-AAV was successfully constructed. The expression of 6xHis in CRL-1730 cells under the regulation of HRE was assayed using the immunohistochemical method and results showed that the expression was positive in the experimental group. Myocardium perfusion MRI displayed that the infracted area significantly decreased under the action of pSS-HRE-CMV-NT4-PR39-PolyA-AAV. The artificial minimal HRE in CRL-1730 cells effectively and rapidly regulates the expression of the downstream gene NT4-TAT-His-PR39 of the CMV promoter. Recombinant pSS-HRE-CMV-NT4-PR39-PolyA-AAV promotes neoangiogenesis in the ischemic area, reduces the area of infarction and improves heart function.
View References
1
|
Wenger RH, Stiehl DP and Camenish G:
Integration of oxygen signaling at the consensus HRE. Sci STKE.
306:re122005.PubMed/NCBI
|
2
|
Beck T, Weinmann R and Caro G:
Characterization of hypoxia-responsive enhancer in the human
erythropoietin gene shows presence of hypoxia-inducible 120-kD
nuclear DNA-binding protein in erythropoietin-producing and
nonproducing cells. Blood. 82:704–711. 1993.
|
3
|
Shen GM, Zhao YZ, Chen MT, et al:
Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake
through inducing VLDLR under hypoxia. Biochem J. 441:675–683. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Fijalkowska I, Xu W, Comhair SA, et al:
Hypoxia inducible-factor1alpha regulates the metabolic shift of
pulmonary hypertensive endothelial cells. Am J Pathol.
176:1130–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Su H, Arakawa-Hoyt J and Kan YW:
Adeno-associated viral vector-mediated hypoxia response
element-regulated gene expression in mouse ischemic heart model.
Proc Natl Acad Sci USA. 99:9480–9485. 2002. View Article : Google Scholar : PubMed/NCBI
|
6
|
Shen F, Fan Y, Su H, et al:
Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene
transfer promotes angiogenesis following focal cerebral ischemia in
mice. Gene Ther. 15:30–39. 2008. View Article : Google Scholar
|
7
|
Semenza GL, Roth PH, Fang HM and Wang GL:
Transcriptional regulation of genes encoding glycolytic eazymes by
hypoxia-inducible factor-1. J Biol Chem. 269:23757–23763.
1994.PubMed/NCBI
|
8
|
Hu HW, Li XK, Zheng RY, Xiao J, Zeng JQ
and Hou ST: bFGF expression mediated by a hypoxia-regulated
adenoviral vector protects PC12 cell death induced by serum
deprivation. Biochem Biophys Res Commun. 390:115–120. 2009.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Shi Q, Zhang P, Zhang J, Chen X, Lu H,
Tian Y, Parker TL and Liu Y: Adenovirus-mediated brain-derived
neurotrophic factor expression regulated by hypoxia response
element protects brain from injury of transient middle cerebral
artery occlusion in mice. Neurosci Lett. 465:220–225. 2009.
View Article : Google Scholar
|
10
|
Kaluz S, Kaluzová M and Stanbridge EJ:
Rational design of minimal hypoxia-inducible enhancers. Biochem
Biophys Res Commun. 370:613–618. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Springer ML, Chen AS, Kraft PE, et al:
VEGF gene delivery to muscle: potential role for vasculogenesis in
adults. Mol Cell. 2:549–558. 1998. View Article : Google Scholar : PubMed/NCBI
|
12
|
Park MS, Ravi V and Araujo DM: Inhibiting
the VEGF-VEGFR pathway in angiosarcoma, epithelioid
hemangioendothelioma, and hemangiopericytoma/solitary fibrous
tumor. Curr Opin Oncol. 22:351–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lalwani AK, Walsh BJ, Carvalho GJ,
Muzyczka N and Mhatre AN: Expression of adenoassociated virus
integrated transgene within the mammalian vestibular organs. Am J
Otol. 19:390–395. 1998.PubMed/NCBI
|